+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Isothermal Nucleic Acid Amplification Market - Global Forecast 2026-2032

  • Report

  • 184 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6277775
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Introduction to Isothermal Nucleic Acid Amplification

Isothermal nucleic acid amplification enables DNA or RNA target sequences to be amplified at a constant temperature, avoiding the repeated heating and cooling cycles associated with conventional polymerase chain reaction workflows. Major approaches include loop-mediated amplification, recombinase polymerase amplification, helicase-dependent amplification, nucleic acid sequence-based amplification, and transcription-mediated amplification. The field is relevant to molecular diagnostics, infectious-disease testing, food and environmental analysis, veterinary applications, and decentralized testing because it can support rapid workflows with compact instrumentation and simplified thermal requirements.

Transformative Shifts in Isothermal Amplification Workflows

The landscape is shifting from laboratory-centered testing toward portable, near-patient, and field-deployable workflows. Assay developers are prioritizing shorter processing times, improved tolerance to inhibitors, multiplex detection, integrated sample preparation, and clearer visual or digital readouts. Cartridge-based systems and microfluidic platforms are helping combine extraction, amplification, and detection, while improved primer and probe design is addressing nonspecific amplification and interpretation challenges. Regulatory validation, quality controls, contamination management, and reproducibility remain essential as the technology moves into more demanding clinical and nonclinical settings.

Artificial Intelligence’s Role in Assay Design and Interpretation

Artificial intelligence is increasingly relevant to sequence selection, primer and probe optimization, assay specificity assessment, and interpretation of complex amplification signals. Machine-learning methods can help identify sequence regions, compare genomic variation, and support the design of multiplex panels, although their outputs require laboratory verification and appropriate training data. AI can also assist with image-based readouts, anomaly detection, quality control, and result triage in decentralized instruments. Its practical value depends on transparent validation, protection against data bias, secure handling of genomic information, and integration with laboratory quality systems rather than replacing experimental confirmation.

Regional Insights Across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific

North America benefits from established molecular-testing infrastructure, strong translational research capacity, and demand for decentralized diagnostic workflows. Europe emphasizes analytical validation, data protection, interoperability, and conformity with medical-device requirements, while the European Union provides a particularly important regulatory and procurement context. Asia-Pacific combines advanced instrument development in economies such as Japan, South Korea, Australia, and China with substantial needs for scalable, accessible testing across diverse healthcare settings. Latin America is shaped by uneven laboratory capacity, infectious-disease priorities, and the value of rugged, lower-complexity platforms. The Middle East is investing in healthcare modernization and specialized diagnostics, while Africa presents strong use cases for portable testing, surveillance, and decentralized services alongside infrastructure, supply-chain, and workforce constraints.

Group-Level Priorities Across ASEAN, BRICS, the European Union, G7, GCC, and NATO

ASEAN countries share priorities around affordable deployment, regional manufacturing, cross-border disease surveillance, and solutions that perform reliably in decentralized environments. BRICS members span different regulatory and health-system conditions but collectively highlight domestic production, research collaboration, and diagnostic resilience. The European Union places weight on harmonized regulation, clinical evidence, sustainability, and interoperable health data. G7 countries generally emphasize high evidentiary standards, advanced research, cybersecurity, and integration with established laboratory networks. GCC members are focused on healthcare modernization, specialized clinical capacity, and supply security, while NATO-related health systems may value rapid, mobile, and resilient testing capabilities for civilian preparedness and operational settings.

Country-Level Perspectives on Adoption and Implementation

Australia is well positioned for decentralized testing across geographically dispersed communities and public-health surveillance. Brazil and Mexico face varied regional access conditions, making robustness, affordability, and local support important. Canada and the United States combine sophisticated research and clinical infrastructure with interest in near-patient and home-adjacent testing. China is advancing domestic biotechnology and manufacturing capabilities, while India’s large and diverse healthcare environment favors cost-conscious, scalable platforms. Japan and South Korea emphasize precision, miniaturization, automation, and quality. In Europe, France, Germany, Italy, Spain, and the United Kingdom are shaped by strong clinical systems, regulatory scrutiny, and demand for reliable integration into laboratory and public-health workflows. Russia’s priorities include diagnostic autonomy, regional accessibility, and supply resilience, subject to regulatory and infrastructure conditions.

Actionable Priorities for Industry Leaders

Leaders should select applications where constant-temperature amplification offers a clear operational advantage, then validate performance against established reference methods using representative specimens and realistic interferents. Product development should address the entire workflow: sampling, extraction, amplification, contamination control, result interpretation, connectivity, and waste handling. Regional strategies should align claims with local regulatory pathways, procurement practices, reimbursement conditions, and laboratory capabilities. Partnerships with clinical sites, public-health agencies, distributors, and manufacturing organizations can improve validation and implementation. Companies should also invest in robust quality systems, transparent AI governance where applicable, supply-chain redundancy, user training, and post-deployment surveillance.

Research Methodology for the Executive Summary

This executive summary uses a technology- and application-focused synthesis of publicly documented scientific, clinical, regulatory, and implementation evidence concerning isothermal nucleic acid amplification. The assessment compares amplification mechanisms, workflow requirements, detection formats, use environments, validation considerations, and regional operating conditions. Regional, group, and country observations are qualitative and reflect documented differences in healthcare infrastructure, diagnostic priorities, regulatory environments, research capacity, and deployment needs. No market estimates, market shares, forecasts, or company-specific claims are included; conclusions should be updated as new peer-reviewed studies, regulatory decisions, and field-validation results become available.

Conclusion: Building Reliable, Accessible Isothermal Testing

Isothermal nucleic acid amplification offers a practical route to faster and more portable molecular testing when assay specificity, contamination control, sample preparation, and result interpretation are engineered as one system. Its strongest opportunities are linked to decentralized diagnostics, surveillance, resource-constrained environments, and workflows requiring compact equipment or simplified thermal control. Sustainable adoption will depend less on amplification speed alone than on clinical evidence, usability, regulatory alignment, manufacturing quality, and integration with health systems. Careful application selection and transparent validation can help translate the technology’s flexibility into dependable real-world testing.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Isothermal Nucleic Acid Amplification Market, by Product Type
7.1. Introduction
7.2. Software And Services
7.3. Reagents And Kits
7.4. Instruments And Platforms
7.5. Consumables And Accessories
8. Isothermal Nucleic Acid Amplification Market, by Technology
8.1. Introduction
8.2. Transcription Mediated Amplification TMA
8.3. Strand Displacement Amplification SDA
8.4. Rolling Circle Amplification RCA
8.5. Recombinase Polymerase Amplification RPA
8.6. Nucleic Acid Sequence Based Amplification NASBA
8.7. Loop Mediated Isothermal Amplification LAMP
8.8. Helicase Dependent Amplification HDA
9. Isothermal Nucleic Acid Amplification Market, by End User
9.1. Introduction
9.2. Veterinary Laboratories
9.3. Reference And Diagnostic Laboratories
9.4. Point Of Care Settings
9.5. Pharmaceutical And Biotechnology Companies
9.6. Hospitals And Clinical Laboratories
9.7. Food Testing Laboratories
9.8. Academic And Research Institutes
10. Isothermal Nucleic Acid Amplification Market, by Application
10.1. Introduction
10.2. Veterinary Diagnostics
10.3. Research And Academic
10.4. Point Of Care Testing
10.5. Industrial Quality Control
10.6. Food Safety Testing
10.7. Environmental Testing
10.8. Clinical Diagnostics
11. Isothermal Nucleic Acid Amplification Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Isothermal Nucleic Acid Amplification Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Isothermal Nucleic Acid Amplification Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Abbott Laboratories
15.2. Atila BioSystems
15.3. bioMérieux SA
15.4. DiaSorin S.p.A.
15.5. Eiken Chemical Co., Ltd.
15.6. Genedrive plc
15.7. Genomtec SA
15.8. Grifols, S.A.
15.9. Hologic, Inc.
15.10. Jena Bioscience GmbH
15.11. LGC Limited
15.12. Lucira Health, Inc.
15.13. Mast Group Ltd.
15.14. Meridian Bioscience, Inc.
15.15. Molbio Diagnostics Pvt. Ltd.
15.16. Molecular Loop Biosciences, Inc.
15.17. New England Biolabs, Inc.
15.18. OptiGene Limited
15.19. QIAGEN N.V.
15.20. QuidelOrtho Corporation
15.21. Tecan Trading AG
15.22. Thermo Fisher Scientific, Inc.
15.23. TwistDx Limited
15.24. Ustar Biotechnologies Hangzhou Ltd.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Isothermal Nucleic Acid Amplification Market, Years Considered for the Study
FIGURE 2. Global Isothermal Nucleic Acid Amplification Market, Research Design
FIGURE 3. Global Isothermal Nucleic Acid Amplification Market, Research Framework
FIGURE 4. Global Isothermal Nucleic Acid Amplification Market, Data Triangulation
FIGURE 5. Global Isothermal Nucleic Acid Amplification Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Isothermal Nucleic Acid Amplification Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Isothermal Nucleic Acid Amplification Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Isothermal Nucleic Acid Amplification Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Isothermal Nucleic Acid Amplification Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Isothermal Nucleic Acid Amplification Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global Isothermal Nucleic Acid Amplification Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Isothermal Nucleic Acid Amplification Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Isothermal Nucleic Acid Amplification Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Isothermal Nucleic Acid Amplification Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Isothermal Nucleic Acid Amplification Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Isothermal Nucleic Acid Amplification Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Isothermal Nucleic Acid Amplification Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Isothermal Nucleic Acid Amplification Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Isothermal Nucleic Acid Amplification Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Isothermal Nucleic Acid Amplification Market Segmentation & Coverage
TABLE 2. Global Isothermal Nucleic Acid Amplification Market Size, 2017-2032 (USD Million)
TABLE 3. Global Isothermal Nucleic Acid Amplification Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Software And Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Software And Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Software And Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Reagents And Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Reagents And Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Reagents And Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Instruments And Platforms Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Instruments And Platforms Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Instruments And Platforms Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Consumables And Accessories Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Consumables And Accessories Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Consumables And Accessories Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Isothermal Nucleic Acid Amplification Market Size, by Technology, 2017-2032 (USD Million)
TABLE 17. Global Transcription Mediated Amplification TMA Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Transcription Mediated Amplification TMA Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Transcription Mediated Amplification TMA Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Strand Displacement Amplification SDA Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Strand Displacement Amplification SDA Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Strand Displacement Amplification SDA Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Rolling Circle Amplification RCA Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Rolling Circle Amplification RCA Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Rolling Circle Amplification RCA Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Recombinase Polymerase Amplification RPA Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Recombinase Polymerase Amplification RPA Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Recombinase Polymerase Amplification RPA Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Nucleic Acid Sequence Based Amplification NASBA Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Nucleic Acid Sequence Based Amplification NASBA Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Nucleic Acid Sequence Based Amplification NASBA Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Loop Mediated Isothermal Amplification LAMP Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Loop Mediated Isothermal Amplification LAMP Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Loop Mediated Isothermal Amplification LAMP Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Helicase Dependent Amplification HDA Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Helicase Dependent Amplification HDA Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Helicase Dependent Amplification HDA Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Isothermal Nucleic Acid Amplification Market Size, by End User, 2017-2032 (USD Million)
TABLE 39. Global Veterinary Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Veterinary Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Veterinary Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Reference And Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Reference And Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Reference And Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Point Of Care Settings Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Point Of Care Settings Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Point Of Care Settings Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Pharmaceutical And Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Pharmaceutical And Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Pharmaceutical And Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Hospitals And Clinical Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Hospitals And Clinical Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Hospitals And Clinical Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Food Testing Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Food Testing Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Food Testing Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Academic And Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Academic And Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Academic And Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Isothermal Nucleic Acid Amplification Market Size, by Application, 2017-2032 (USD Million)
TABLE 61. Global Veterinary Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Veterinary Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Veterinary Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Research And Academic Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Research And Academic Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Research And Academic Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Point Of Care Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Point Of Care Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Point Of Care Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Industrial Quality Control Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Industrial Quality Control Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Industrial Quality Control Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Food Safety Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Food Safety Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Food Safety Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Environmental Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Environmental Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Environmental Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Clinical Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Clinical Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Clinical Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Isothermal Nucleic Acid Amplification Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Asia-Pacific Isothermal Nucleic Acid Amplification Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Asia-Pacific Isothermal Nucleic Acid Amplification Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 85. Asia-Pacific Isothermal Nucleic Acid Amplification Market Size, by Technology, 2017-2032 (USD Million)
TABLE 86. Asia-Pacific Isothermal Nucleic Acid Amplification Market Size, by End User, 2017-2032 (USD Million)
TABLE 87. Asia-Pacific Isothermal Nucleic Acid Amplification Market Size, by Application, 2017-2032 (USD Million)
TABLE 88. North America Isothermal Nucleic Acid Amplification Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. North America Isothermal Nucleic Acid Amplification Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 90. North America Isothermal Nucleic Acid Amplification Market Size, by Technology, 2017-2032 (USD Million)
TABLE 91. North America Isothermal Nucleic Acid Amplification Market Size, by End User, 2017-2032 (USD Million)
TABLE 92. North America Isothermal Nucleic Acid Amplification Market Size, by Application, 2017-2032 (USD Million)
TABLE 93. Latin America Isothermal Nucleic Acid Amplification Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Latin America Isothermal Nucleic Acid Amplification Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 95. Latin America Isothermal Nucleic Acid Amplification Market Size, by Technology, 2017-2032 (USD Million)
TABLE 96. Latin America Isothermal Nucleic Acid Amplification Market Size, by End User, 2017-2032 (USD Million)
TABLE 97. Latin America Isothermal Nucleic Acid Amplification Market Size, by Application, 2017-2032 (USD Million)
TABLE 98. Europe Isothermal Nucleic Acid Amplification Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Europe Isothermal Nucleic Acid Amplification Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 100. Europe Isothermal Nucleic Acid Amplification Market Size, by Technology, 2017-2032 (USD Million)
TABLE 101. Europe Isothermal Nucleic Acid Amplification Market Size, by End User, 2017-2032 (USD Million)
TABLE 102. Europe Isothermal Nucleic Acid Amplification Market Size, by Application, 2017-2032 (USD Million)
TABLE 103. Middle East Isothermal Nucleic Acid Amplification Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Middle East Isothermal Nucleic Acid Amplification Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 105. Middle East Isothermal Nucleic Acid Amplification Market Size, by Technology, 2017-2032 (USD Million)
TABLE 106. Middle East Isothermal Nucleic Acid Amplification Market Size, by End User, 2017-2032 (USD Million)
TABLE 107. Middle East Isothermal Nucleic Acid Amplification Market Size, by Application, 2017-2032 (USD Million)
TABLE 108. Africa Isothermal Nucleic Acid Amplification Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Africa Isothermal Nucleic Acid Amplification Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 110. Africa Isothermal Nucleic Acid Amplification Market Size, by Technology, 2017-2032 (USD Million)
TABLE 111. Africa Isothermal Nucleic Acid Amplification Market Size, by End User, 2017-2032 (USD Million)
TABLE 112. Africa Isothermal Nucleic Acid Amplification Market Size, by Application, 2017-2032 (USD Million)
TABLE 113. Global Isothermal Nucleic Acid Amplification Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. ASEAN Isothermal Nucleic Acid Amplification Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. ASEAN Isothermal Nucleic Acid Amplification Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 116. ASEAN Isothermal Nucleic Acid Amplification Market Size, by Technology, 2017-2032 (USD Million)
TABLE 117. ASEAN Isothermal Nucleic Acid Amplification Market Size, by End User, 2017-2032 (USD Million)
TABLE 118. ASEAN Isothermal Nucleic Acid Amplification Market Size, by Application, 2017-2032 (USD Million)
TABLE 119. GCC Isothermal Nucleic Acid Amplification Market Size, by Group, 2017-2032 (USD Million)
TABLE 120. GCC Isothermal Nucleic Acid Amplification Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 121. GCC Isothermal Nucleic Acid Amplification Market Size, by Technology, 2017-2032 (USD Million)
TABLE 122. GCC Isothermal Nucleic Acid Amplification Market Size, by End User, 2017-2032 (USD Million)
TABLE 123. GCC Isothermal Nucleic Acid Amplification Market Size, by Application, 2017-2032 (USD Million)
TABLE 124. European Union Isothermal Nucleic Acid Amplification Market Size, by Group, 2017-2032 (USD Million)
TABLE 125. European Union Isothermal Nucleic Acid Amplification Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 126. European Union Isothermal Nucleic Acid Amplification Market Size, by Technology, 2017-2032 (USD Million)
TABLE 127. European Union Isothermal Nucleic Acid Amplification Market Size, by End User, 2017-2032 (USD Million)
TABLE 128. European Union Isothermal Nucleic Acid Amplification Market Size, by Application, 2017-2032 (USD Million)
TABLE 129. BRICS Isothermal Nucleic Acid Amplification Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. BRICS Isothermal Nucleic Acid Amplification Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 131. BRICS Isothermal Nucleic Acid Amplification Market Size, by Technology, 2017-2032 (USD Million)
TABLE 132. BRICS Isothermal Nucleic Acid Amplification Market Size, by End User, 2017-2032 (USD Million)
TABLE 133. BRICS Isothermal Nucleic Acid Amplification Market Size, by Application, 2017-2032 (USD Million)
TABLE 134. G7 Isothermal Nucleic Acid Amplification Market Size, by Group, 2017-2032 (USD Million)
TABLE 135. G7 Isothermal Nucleic Acid Amplification Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 136. G7 Isothermal Nucleic Acid Amplification Market Size, by Technology, 2017-2032 (USD Million)
TABLE 137. G7 Isothermal Nucleic Acid Amplification Market Size, by End User, 2017-2032 (USD Million)
TABLE 138. G7 Isothermal Nucleic Acid Amplification Market Size, by Application, 2017-2032 (USD Million)
TABLE 139. NATO Isothermal Nucleic Acid Amplification Market Size, by Group, 2017-2032 (USD Million)
TABLE 140. NATO Isothermal Nucleic Acid Amplification Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 141. NATO Isothermal Nucleic Acid Amplification Market Size, by Technology, 2017-2032 (USD Million)
TABLE 142. NATO Isothermal Nucleic Acid Amplification Market Size, by End User, 2017-2032 (USD Million)
TABLE 143. NATO Isothermal Nucleic Acid Amplification Market Size, by Application, 2017-2032 (USD Million)
TABLE 144. Global Isothermal Nucleic Acid Amplification Market Size, by Country, 2017-2032 (USD Million)
TABLE 145. United States Isothermal Nucleic Acid Amplification Market Size, 2017-2032 (USD Million)
TABLE 146. United States Isothermal Nucleic Acid Amplification Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 147. United States Isothermal Nucleic Acid Amplification Market Size, by Technology, 2017-2032 (USD Million)
TABLE 148. United States Isothermal Nucleic Acid Amplification Market Size, by End User, 2017-2032 (USD Million)
TABLE 149. United States Isothermal Nucleic Acid Amplification Market Size, by Application, 2017-2032 (USD Million)
TABLE 150. Canada Isothermal Nucleic Acid Amplification Market Size, 2017-2032 (USD Million)
TABLE 151. Canada Isothermal Nucleic Acid Amplification Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 152. Canada Isothermal Nucleic Acid Amplification Market Size, by Technology, 2017-2032 (USD Million)
TABLE 153. Canada Isothermal Nucleic Acid Amplification Market Size, by End User, 2017-2032 (USD Million)
TABLE 154. Canada Isothermal Nucleic Acid Amplification Market Size, by Application, 2017-2032 (USD Million)
TABLE 155. Mexico Isothermal Nucleic Acid Amplification Market Size, 2017-2032 (USD Million)
TABLE 156. Mexico Isothermal Nucleic Acid Amplification Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 157. Mexico Isothermal Nucleic Acid Amplification Market Size, by Technology, 2017-2032 (USD Million)
TABLE 158. Mexico Isothermal Nucleic Acid Amplification Market Size, by End User, 2017-2032 (USD Million)
TABLE 159. Mexico Isothermal Nucleic Acid Amplification Market Size, by Application, 2017-2032 (USD Million)
TABLE 160. Brazil Isothermal Nucleic Acid Amplification Market Size, 2017-2032 (USD Million)
TABLE 161. Brazil Isothermal Nucleic Acid Amplification Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 162. Brazil Isothermal Nucleic Acid Amplification Market Size, by Technology, 2017-2032 (USD Million)
TABLE 163. Brazil Isothermal Nucleic Acid Amplification Market Size, by End User, 2017-2032 (USD Million)
TABLE 164. Brazil Isothermal Nucleic Acid Amplification Market Size, by Application, 2017-2032 (USD Million)
TABLE 165. United Kingdom Isothermal Nucleic Acid Amplification Market Size, 2017-2032 (USD Million)
TABLE 166. United Kingdom Isothermal Nucleic Acid Amplification Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 167. United Kingdom Isothermal Nucleic Acid Amplification Market Size, by Technology, 2017-2032 (USD Million)
TABLE 168. United Kingdom Isothermal Nucleic Acid Amplification Market Size, by End User, 2017-2032 (USD Million)
TABLE 169. United Kingdom Isothermal Nucleic Acid Amplification Market Size, by Application, 2017-2032 (USD Million)
TABLE 170. Germany Isothermal Nucleic Acid Amplification Market Size, 2017-2032 (USD Million)
TABLE 171. Germany Isothermal Nucleic Acid Amplification Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 172. Germany Isothermal Nucleic Acid Amplification Market Size, by Technology, 2017-2032 (USD Million)
TABLE 173. Germany Isothermal Nucleic Acid Amplification Market Size, by End User, 2017-2032 (USD Million)
TABLE 174. Germany Isothermal Nucleic Acid Amplification Market Size, by Application, 2017-2032 (USD Million)
TABLE 175. France Isothermal Nucleic Acid Amplification Market Size, 2017-2032 (USD Million)
TABLE 176. France Isothermal Nucleic Acid Amplification Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 177. France Isothermal Nucleic Acid Amplification Market Size, by Technology, 2017-2032 (USD Million)
TABLE 178. France Isothermal Nucleic Acid Amplification Market Size, by End User, 2017-2032 (USD Million)
TABLE 179. France Isothermal Nucleic Acid Amplification Market Size, by Application, 2017-2032 (USD Million)
TABLE 180. Russia Isothermal Nucleic Acid Amplification Market Size, 2017-2032 (USD Million)
TABLE 181. Russia Isothermal Nucleic Acid Amplification Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 182. Russia Isothermal Nucleic Acid Amplification Market Size, by Technology, 2017-2032 (USD Million)
TABLE 183. Russia Isothermal Nucleic Acid Amplification Market Size, by End User, 2017-2032 (USD Million)
TABLE 184. Russia Isothermal Nucleic Acid Amplification Market Size, by Application, 2017-2032 (USD Million)
TABLE 185. Italy Isothermal Nucleic Acid Amplification Market Size, 2017-2032 (USD Million)
TABLE 186. Italy Isothermal Nucleic Acid Amplification Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 187. Italy Isothermal Nucleic Acid Amplification Market Size, by Technology, 2017-2032 (USD Million)
TABLE 188. Italy Isothermal Nucleic Acid Amplification Market Size, by End User, 2017-2032 (USD Million)
TABLE 189. Italy Isothermal Nucleic Acid Amplification Market Size, by Application, 2017-2032 (USD Million)
TABLE 190. Spain Isothermal Nucleic Acid Amplification Market Size, 2017-2032 (USD Million)
TABLE 191. Spain Isothermal Nucleic Acid Amplification Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 192. Spain Isothermal Nucleic Acid Amplification Market Size, by Technology, 2017-2032 (USD Million)
TABLE 193. Spain Isothermal Nucleic Acid Amplification Market Size, by End User, 2017-2032 (USD Million)
TABLE 194. Spain Isothermal Nucleic Acid Amplification Market Size, by Application, 2017-2032 (USD Million)
TABLE 195. China Isothermal Nucleic Acid Amplification Market Size, 2017-2032 (USD Million)
TABLE 196. China Isothermal Nucleic Acid Amplification Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 197. China Isothermal Nucleic Acid Amplification Market Size, by Technology, 2017-2032 (USD Million)
TABLE 198. China Isothermal Nucleic Acid Amplification Market Size, by End User, 2017-2032 (USD Million)
TABLE 199. China Isothermal Nucleic Acid Amplification Market Size, by Application, 2017-2032 (USD Million)
TABLE 200. India Isothermal Nucleic Acid Amplification Market Size, 2017-2032 (USD Million)
TABLE 201. India Isothermal Nucleic Acid Amplification Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 202. India Isothermal Nucleic Acid Amplification Market Size, by Technology, 2017-2032 (USD Million)
TABLE 203. India Isothermal Nucleic Acid Amplification Market Size, by End User, 2017-2032 (USD Million)
TABLE 204. India Isothermal Nucleic Acid Amplification Market Size, by Application, 2017-2032 (USD Million)
TABLE 205. Japan Isothermal Nucleic Acid Amplification Market Size, 2017-2032 (USD Million)
TABLE 206. Japan Isothermal Nucleic Acid Amplification Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 207. Japan Isothermal Nucleic Acid Amplification Market Size, by Technology, 2017-2032 (USD Million)
TABLE 208. Japan Isothermal Nucleic Acid Amplification Market Size, by End User, 2017-2032 (USD Million)
TABLE 209. Japan Isothermal Nucleic Acid Amplification Market Size, by Application, 2017-2032 (USD Million)
TABLE 210. Australia Isothermal Nucleic Acid Amplification Market Size, 2017-2032 (USD Million)
TABLE 211. Australia Isothermal Nucleic Acid Amplification Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 212. Australia Isothermal Nucleic Acid Amplification Market Size, by Technology, 2017-2032 (USD Million)
TABLE 213. Australia Isothermal Nucleic Acid Amplification Market Size, by End User, 2017-2032 (USD Million)
TABLE 214. Australia Isothermal Nucleic Acid Amplification Market Size, by Application, 2017-2032 (USD Million)
TABLE 215. South Korea Isothermal Nucleic Acid Amplification Market Size, 2017-2032 (USD Million)
TABLE 216. South Korea Isothermal Nucleic Acid Amplification Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 217. South Korea Isothermal Nucleic Acid Amplification Market Size, by Technology, 2017-2032 (USD Million)
TABLE 218. South Korea Isothermal Nucleic Acid Amplification Market Size, by End User, 2017-2032 (USD Million)
TABLE 219. South Korea Isothermal Nucleic Acid Amplification Market Size, by Application, 2017-2032 (USD Million)
TABLE 220. Global Isothermal Nucleic Acid Amplification Market Share, by Key Player, 2025
TABLE 221. Global Isothermal Nucleic Acid Amplification Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • Atila BioSystems
  • bioMérieux SA
  • DiaSorin S.p.A.
  • Eiken Chemical Co., Ltd.
  • Genedrive plc
  • Genomtec SA
  • Grifols, S.A.
  • Hologic, Inc.
  • Jena Bioscience GmbH
  • LGC Limited
  • Lucira Health, Inc.
  • Mast Group Ltd.
  • Meridian Bioscience, Inc.
  • Molbio Diagnostics Pvt. Ltd.
  • Molecular Loop Biosciences, Inc.
  • New England Biolabs, Inc.
  • OptiGene Limited
  • QIAGEN N.V.
  • QuidelOrtho Corporation
  • Tecan Trading AG
  • Thermo Fisher Scientific, Inc.
  • TwistDx Limited
  • Ustar Biotechnologies Hangzhou Ltd.